Trent shares rose sharply after a strong Q2 business update, adding over Rs 17,540 crore to its market capitalisation. The surge lifted the value of LIC’s stake in the Zudio parent by more than Rs 531 crore in a single session. Trent also crossed 1,000 Zudio stores during the quarter.
European shares climbed to near one-week highs, led by healthcare stocks, while easing eurozone bond yields offered some relief. Investors remained focused on fiscal pressures, political uncertainty and upcoming economic data for clues on the region’s outlook.
AMD plans to substantially increase chip supplies in 2027 as demand for AI processors accelerates. CEO Lisa Su is working with key suppliers in Taiwan and South Korea to expand manufacturing and secure advanced wafer and memory capacity.
Jio Platforms is reportedly seeking a valuation of around Rs 11 lakh crore for its planned IPO, below earlier estimates of up to $170 billion. The telecom and digital services arm of Reliance Industries could launch the issue in the week of October 19 and list before October 30, Bloomberg reported.
SRIT India shares rose 19% from the IPO price after making a strong debut on the NSE. The stock, however, fell short of grey market expectations. With the company’s digital technology services business gaining traction, analysts highlight revenue growth, profitability, execution and cash flows as key factors for investors.
High-yield bonds, often labelled “junkâ€, have historically delivered a large share of stock market returns with lower volatility. Saurabh Mukherjea explains how coupons, seniority in repayment and diversification can make them useful in portfolios.
The Bank of Japan may signal later this month that underlying inflation has reached its 2% target, strengthening expectations for a December rate hike. While policymakers remain cautious after recent increases, steady wages, rising prices and yen weakness could support further tightening as the BOJ gradually normalises monetary policy.
Meesho shares rose after strong growth in its Content Commerce business, with NMV increasing 152% year-on-year. Brokerages remain divided, with UBS and Jefferies positive on the stock, while Nomura has a Reduce call.
Indian banks are heading into the Q2 earnings season with strong loan growth, helped by FCNR(B) deposit inflows, but margins are likely to remain under pressure. Analysts expect healthy earnings growth on lower credit costs and stable asset quality, while favouring large private banks such as HDFC Bank, ICICI Bank and Kotak Mahindra Bank.
Motilal Oswal initiated coverage on Molbio Diagnostics with a Buy rating and ₹1,800 target, implying 21% upside. The brokerage sees strong growth potential from decentralised molecular diagnostics, led by Molbio’s Truenat platform, which has 12,500+ devices across 90+ countries and 43 assays for 30 diseases.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.